You are here: Welcome » George Church

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
george_church [2023/01/16 19:56]
liam
george_church [2023/01/22 21:06] (current)
liam [Jeffrey Epstein]
Line 15: Line 15:
 On October 30, 2017, Church was awarded the title of Honorary Professor at [[Zhejiang University]].((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj)) After the award ceremony, Church delivered a keynote speech titled “Technologies for Reading & Editing DNA and Medical Applications” at [[Xinglin Forum]], a high-level academic activity hosted by ZJU’s School of Medicine. On October 30, 2017, Church was awarded the title of Honorary Professor at [[Zhejiang University]].((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj)) After the award ceremony, Church delivered a keynote speech titled “Technologies for Reading & Editing DNA and Medical Applications” at [[Xinglin Forum]], a high-level academic activity hosted by ZJU’s School of Medicine.
  
 +On May 1, 2018, Church co-led the second [[Genome Project-write]] (GP-write) "Scientific Working Meeting" at the [[Center of Excellence for Engineering Biology]], where he reportedly networked with [[Bryan Bishop]] and [[Max Berry]].((//GP-write Scientific Working Meeting | May 1, 2018.// The Center of Excellence for Engineering Biology. Retrieved January 22, 2023, from https://archive.ph/LOm33)) ((Shanks, P. (2019, February 8). //The Bitcoin Baby Project.// Center for Genetics and Society. https://web.archive.org/web/20230122195002/https://www.geneticsandsociety.org/biopolitical-times/bitcoin-baby-project)) In response to the pair's request for advice on their new [[designer baby]] startup, Church told them to consult with ethicists.((Regalado, A. (2019, February 1). //The DIY designer baby project funded with Bitcoin.// MIT Technology Review. https://archive.ph/lgB0w))
 ==== COVID-19 ==== ==== COVID-19 ====
  
Line 29: Line 30:
 | [[AltLabs]]  | Scientific Advisor((Alley, E. C., Turpin, M., Liu, A. B., Kulp-McDowall, T., Swett, J., Edison, R., Von Stetina, S. E., Church, G. M., & Esvelt, K. M. (2020). //A machine learning toolkit for genetic engineering attribution to facilitate biosecurity.// Nature Communications, 11(1). https://doi.org/10.1038/s41467-020-19612-0))  | | [[AltLabs]]  | Scientific Advisor((Alley, E. C., Turpin, M., Liu, A. B., Kulp-McDowall, T., Swett, J., Edison, R., Von Stetina, S. E., Church, G. M., & Esvelt, K. M. (2020). //A machine learning toolkit for genetic engineering attribution to facilitate biosecurity.// Nature Communications, 11(1). https://doi.org/10.1038/s41467-020-19612-0))  |
 | [[medical_technology_companies:Alveo Technologies]]  | Advisor((Chiarello, R. (2019, May 1). //Famed American Geneticist, George Church, Joins Alveo’s Scientific Advisory Board.// Alveo Technologies. https://archive.ph/inv3o))  | | [[medical_technology_companies:Alveo Technologies]]  | Advisor((Chiarello, R. (2019, May 1). //Famed American Geneticist, George Church, Joins Alveo’s Scientific Advisory Board.// Alveo Technologies. https://archive.ph/inv3o))  |
 +| [[ARCH Venture Partners]]  | -  |
 | [[pharmaceutical_companies:AuraVax Therapeutics]]  | Scientific Advisor((//Company.// AuraVax. Retrieved November 28, 2022, from https://web.archive.org/web/20221128184427/https://www.auravax.com/company/))  | | [[pharmaceutical_companies:AuraVax Therapeutics]]  | Scientific Advisor((//Company.// AuraVax. Retrieved November 28, 2022, from https://web.archive.org/web/20221128184427/https://www.auravax.com/company/))  |
 | [[Betterhumans]]  | Scientific Advisor((//Meet Our Team.// Betterhumans. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074336/https://www.betterhumans.org/team.html))  | | [[Betterhumans]]  | Scientific Advisor((//Meet Our Team.// Betterhumans. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074336/https://www.betterhumans.org/team.html))  |
Line 42: Line 44:
 | [[medical_technology_companies:Complete Genomics]]  | Advisory board member((//Advisory Board.// Complete Genomics. Retrieved November 27, 2022, from https://web.archive.org/web/20221127145415/https://www.completegenomics.com/about-us/complete-genomics-advisory-board/))  | | [[medical_technology_companies:Complete Genomics]]  | Advisory board member((//Advisory Board.// Complete Genomics. Retrieved November 27, 2022, from https://web.archive.org/web/20221127145415/https://www.completegenomics.com/about-us/complete-genomics-advisory-board/))  |
 | [[Consortium for Space Genetics]]  | Faculty member((//George M. Church, Ph.D.// Consortium for Space Genetics. Retrieved January 12, 2023, from https://archive.ph/MI26l))  | | [[Consortium for Space Genetics]]  | Faculty member((//George M. Church, Ph.D.// Consortium for Space Genetics. Retrieved January 12, 2023, from https://archive.ph/MI26l))  |
 +| [[CRISPR Journal]]  | -  |
 | [[Duke University]]  | Researcher  | | [[Duke University]]  | Researcher  |
 | [[Effective Altruism Global]]  | Speaker at EA Global Boston in 2017((//Home.// EA Global Boston. Retrieved January 13, 2023, from https://web.archive.org/web/20230113035038/https://boston.eaglobal.org/)) ((Labenz, A. (2017, April 1). //Applications are open for EA Global Boston.// Effective Altruism Forum. https://web.archive.org/web/20221207211135/https://forum.effectivealtruism.org/posts/Rh5a5CHhpP955Winn/applications-are-open-for-ea-global-boston))  | | [[Effective Altruism Global]]  | Speaker at EA Global Boston in 2017((//Home.// EA Global Boston. Retrieved January 13, 2023, from https://web.archive.org/web/20230113035038/https://boston.eaglobal.org/)) ((Labenz, A. (2017, April 1). //Applications are open for EA Global Boston.// Effective Altruism Forum. https://web.archive.org/web/20221207211135/https://forum.effectivealtruism.org/posts/Rh5a5CHhpP955Winn/applications-are-open-for-ea-global-boston))  |
 +| [[Fidelity]]  | -  |
 | [[Flagship Pioneering]]  | "Friend", Founder of many companies funded by Flagship((//From Primordial Soup to Nanopores: A Conversation With George Church.// (2018, November 5). Flagship Pioneering. https://web.archive.org/web/20230115044446/https://www.flagshippioneering.com/stories/q-a-with-george-church))  | | [[Flagship Pioneering]]  | "Friend", Founder of many companies funded by Flagship((//From Primordial Soup to Nanopores: A Conversation With George Church.// (2018, November 5). Flagship Pioneering. https://web.archive.org/web/20230115044446/https://www.flagshippioneering.com/stories/q-a-with-george-church))  |
 +| [[Founders Fund]]  | -  |
 | [[Franklin Institute]]  | Bower Award and Prize for Achievement in Science((//Bower Laureates.// The Franklin Institute. Retrieved January 13, 2023, from https://web.archive.org/web/20230113001037/https://www.fi.edu/bower-laureates))  | | [[Franklin Institute]]  | Bower Award and Prize for Achievement in Science((//Bower Laureates.// The Franklin Institute. Retrieved January 13, 2023, from https://web.archive.org/web/20230113001037/https://www.fi.edu/bower-laureates))  |
 | [[Future of Life Institute]]  | External advisor((//George Church.// Future of Life Institute. Retrieved January 13, 2023, from https://archive.ph/w7Cez))  | | [[Future of Life Institute]]  | External advisor((//George Church.// Future of Life Institute. Retrieved January 13, 2023, from https://archive.ph/w7Cez))  |
Line 53: Line 58:
 | [[Genspace]]  | Advisor((Loria, K. (2015, May 1). //The process used to edit the genes of human embryos is so easy you could do it in a community bio-hacker space.// Yahoo! Finance. https://archive.ph/nSTTa))  | | [[Genspace]]  | Advisor((Loria, K. (2015, May 1). //The process used to edit the genes of human embryos is so easy you could do it in a community bio-hacker space.// Yahoo! Finance. https://archive.ph/nSTTa))  |
 | [[George Church Institute of Regenesis]]  | Director((Bio-IT World Staff. (2017, October 27). //BGI Launches George Church Institute.// Bio-IT World. https://archive.ph/ufRYd))  | | [[George Church Institute of Regenesis]]  | Director((Bio-IT World Staff. (2017, October 27). //BGI Launches George Church Institute.// Bio-IT World. https://archive.ph/ufRYd))  |
 +| [[Google Ventures]]  | -  |
 | [[Harvard Alumni Entrepreneurs]]  | Past speaker((//The Future of Synthetic Biology with Prof. George Church.// (2020, September 22). Harvard Alumni Entrepreneurs. https://archive.ph/v2QcV))  | | [[Harvard Alumni Entrepreneurs]]  | Past speaker((//The Future of Synthetic Biology with Prof. George Church.// (2020, September 22). Harvard Alumni Entrepreneurs. https://archive.ph/v2QcV))  |
 | [[Harvard College Effective Altruism]]  | Speaker((Eyal, N. (2014, October 18). //Harvard Effective Altruism: George Church this Monday.// Bill of Health. https://web.archive.org/web/20230113074847/https://blog.petrieflom.law.harvard.edu/2014/10/18/harvard-effective-altruism-george-church-this-monday/))  | | [[Harvard College Effective Altruism]]  | Speaker((Eyal, N. (2014, October 18). //Harvard Effective Altruism: George Church this Monday.// Bill of Health. https://web.archive.org/web/20230113074847/https://blog.petrieflom.law.harvard.edu/2014/10/18/harvard-effective-altruism-george-church-this-monday/))  |
Line 62: Line 68:
 | [[medical_technology_companies:Illumina]]  | -  | | [[medical_technology_companies:Illumina]]  | -  |
 | [[medical_technology_companies:INanoBio]]  | Advisor((//Scientific Board of Advisors.// INanoBio. Retrieved December 8, 2018, from https://web.archive.org/web/20181208022354/http://www.inanobio.com:80/scientific-advisory-board.php))  | | [[medical_technology_companies:INanoBio]]  | Advisor((//Scientific Board of Advisors.// INanoBio. Retrieved December 8, 2018, from https://web.archive.org/web/20181208022354/http://www.inanobio.com:80/scientific-advisory-board.php))  |
 +| [[In-Q-Tel]]  | -  |
 +| [[Institute for Protein Innovation]]  | -  |
 | [[medical_technology_companies:Intelligent Bio-Systems]]  | Advisor((//Intelligent Bio-Systems - Contacts, Employees, Board Members, Advisors & Alumni.// Crunchbase. Retrieved January 13, 2023, from https://www.crunchbase.com/organization/intelligent-bio-systems/people))  | | [[medical_technology_companies:Intelligent Bio-Systems]]  | Advisor((//Intelligent Bio-Systems - Contacts, Employees, Board Members, Advisors & Alumni.// Crunchbase. Retrieved January 13, 2023, from https://www.crunchbase.com/organization/intelligent-bio-systems/people))  |
 | [[medical_technology_companies:Ion Torrent]]  | Advisor((//Scientific Advisory Board.// Ion Torrent. Retrieved January 14, 2012, from https://web.archive.org/web/20120114061324/http://www.iontorrent.com/scientific-advisory-board))  | | [[medical_technology_companies:Ion Torrent]]  | Advisor((//Scientific Advisory Board.// Ion Torrent. Retrieved January 14, 2012, from https://web.archive.org/web/20120114061324/http://www.iontorrent.com/scientific-advisory-board))  |
 | [[Jeffrey Epstein VI Foundation]]  | Research funding((Church, G. M. (2017, March 25). //Tech transfer.// Church Lab. https://archive.ph/XKy12))  | | [[Jeffrey Epstein VI Foundation]]  | Research funding((Church, G. M. (2017, March 25). //Tech transfer.// Church Lab. https://archive.ph/XKy12))  |
 +| [[Life Extension Advocacy Foundation]] (LEAF)  | -  |
 | [[Life Sciences Research Foundation]]  | Fellow  | | [[Life Sciences Research Foundation]]  | Fellow  |
 | [[Lipper Center for Computational Genetics]]  | Director  | | [[Lipper Center for Computational Genetics]]  | Director  |
 +| [[Longevity Vision Fund]]  | -  |
 | [[pharmaceutical_companies:Lynx Therapeutics]]  | Advisor((//Lynx Augments Its Intellectual Property Portfolio.// (2000, January 20). The Free Library. https://web.archive.org/web/20120908062001/http://www.thefreelibrary.com/Lynx+Augments+Its+Intellectual+Property+Portfolio.-a058723058))  | | [[pharmaceutical_companies:Lynx Therapeutics]]  | Advisor((//Lynx Augments Its Intellectual Property Portfolio.// (2000, January 20). The Free Library. https://web.archive.org/web/20120908062001/http://www.thefreelibrary.com/Lynx+Augments+Its+Intellectual+Property+Portfolio.-a058723058))  |
 | [[Massachusetts Institute of Technology]] (MIT)  | Professor((//George M. Church.// (2022, December 15). Harvard Molecular Technologies. https://web.archive.org/web/20230112232239/https://arep.med.harvard.edu/gmc/))  | | [[Massachusetts Institute of Technology]] (MIT)  | Professor((//George M. Church.// (2022, December 15). Harvard Molecular Technologies. https://web.archive.org/web/20230112232239/https://arep.med.harvard.edu/gmc/))  |
Line 76: Line 86:
 | [[National Academy of Future Physicians and Medical Scientists]]  | Past speaker((//Speakers at the Congress of Future Medical Leaders - Offical Site.// National Academy of Future Physicians and Medical Scientists. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024545/https://www.futuredocs.com/speakers))  | | [[National Academy of Future Physicians and Medical Scientists]]  | Past speaker((//Speakers at the Congress of Future Medical Leaders - Offical Site.// National Academy of Future Physicians and Medical Scientists. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024545/https://www.futuredocs.com/speakers))  |
 | [[National Academy of Sciences]] (NAS)  | Member((Nair, P. (2012). //Profile of George M. Church.// Proceedings of the National Academy of Sciences, 109(30), 11893–11895. https://doi.org/10.1073/pnas.1204148109))  | | [[National Academy of Sciences]] (NAS)  | Member((Nair, P. (2012). //Profile of George M. Church.// Proceedings of the National Academy of Sciences, 109(30), 11893–11895. https://doi.org/10.1073/pnas.1204148109))  |
 +| [[Nature Publishing Group]]  | -  |
 | [[medical_technology_companies:Noblegen Biosciences]]  | Advisor((//Advisors.// Noblegen Biosciences. Retrieved February 18, 2015, from https://web.archive.org/web/20150218153814/http://noblegenbio.com/Advisors.html))  | | [[medical_technology_companies:Noblegen Biosciences]]  | Advisor((//Advisors.// Noblegen Biosciences. Retrieved February 18, 2015, from https://web.archive.org/web/20150218153814/http://noblegenbio.com/Advisors.html))  |
 +| [[Northeast Science Station]]  | -  |
 +| [[Open Humans]]  | -  |
 | [[Personal Genome Project]] (PGP)  | Director  | | [[Personal Genome Project]] (PGP)  | Director  |
 | [[pharmaceutical_companies:Poseida Therapeutics]]  | Gene Therapy Scientific Advisory Board Chair((//George M. Church, Ph.D.// Poseida Therapeutics. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024849/https://poseida.com/george-m-church-ph-d/))  | | [[pharmaceutical_companies:Poseida Therapeutics]]  | Gene Therapy Scientific Advisory Board Chair((//George M. Church, Ph.D.// Poseida Therapeutics. Retrieved January 13, 2023, from https://web.archive.org/web/20230113024849/https://poseida.com/george-m-church-ph-d/))  |
 +| [[Rady Children's Institute for Genomic Medicine]]  | -  |
 +| [[pharmaceutical_companies:Regenerative Bio]]  | -  |
 | [[medical_technology_companies:Roswell Biotechnologies]]  | Advisor((Roswell Biotechnologies, Inc. (2021, October 28). //Roswell Biotechnologies Forms Scientific Advisory Board.// PR Newswire. https://web.archive.org/web/20230114190637/https://www.prnewswire.com/news-releases/roswell-biotechnologies-forms-scientific-advisory-board-301410793.html))  | | [[medical_technology_companies:Roswell Biotechnologies]]  | Advisor((Roswell Biotechnologies, Inc. (2021, October 28). //Roswell Biotechnologies Forms Scientific Advisory Board.// PR Newswire. https://web.archive.org/web/20230114190637/https://www.prnewswire.com/news-releases/roswell-biotechnologies-forms-scientific-advisory-board-301410793.html))  |
 +| [[Scientific American]]  | -  |
 | [[medical_technology_companies:Solexa]]  | -  | | [[medical_technology_companies:Solexa]]  | -  |
 | [[Supercentenarian Research Study]]  | Scientific Advisor((//About Us.// Supercentenarian Research Study. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074556/https://supercentenarianstudy.com/aboutus.html))  | | [[Supercentenarian Research Study]]  | Scientific Advisor((//About Us.// Supercentenarian Research Study. Retrieved January 13, 2023, from https://web.archive.org/web/20230113074556/https://supercentenarianstudy.com/aboutus.html))  |
Line 86: Line 102:
 | [[United States Department of Energy]]  | Funding  | | [[United States Department of Energy]]  | Funding  |
 | [[University of California San Francisco]]  | Post-doctoral researcher  | | [[University of California San Francisco]]  | Post-doctoral researcher  |
 +| [[Winklevoss Capital]]  | -  |
 | [[Wyss Institute for Biologically Inspired Engineering]]  | Director  | | [[Wyss Institute for Biologically Inspired Engineering]]  | Director  |
 | [[medical_technology_companies:XGenomes]]  | Advisor((Shieber, J. (2019, March 15). //XGenomes is bringing DNA sequencing to the masses.// TechCrunch. https://archive.ph/a6ErD))  | | [[medical_technology_companies:XGenomes]]  | Advisor((Shieber, J. (2019, March 15). //XGenomes is bringing DNA sequencing to the masses.// TechCrunch. https://archive.ph/a6ErD))  |
 +| [[XPRIZE]]  | -  |
 +| [[Y Combinator]]  | -  |
 | [[Zhejiang University]]  | Honorary Professor((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj))  | | [[Zhejiang University]]  | Honorary Professor((//World-Renowned Geneticist George Church Named Honorary Professor by ZJU.// (2017, November 6). Zhejiang University. https://archive.ph/8MpGj))  |
  
Back to top